Client News

Home/Client News
Client News 2018-08-28T11:24:45+00:00
June 4, 2018
Checkpoint Therapeutics to Participate in June Investor Conferences
NEW YORK, June 04, 2018 (GLOBE NEWSWIRE) -- Checkpoint Therapeutics, Inc. (“Checkpoint”) (CKPT), a clinical-stage, immuno-oncology biopharmaceutical company focused on the acquisition, development and commercialization ...
June 4, 2018
Eiger Announces HDV Phase 2 Program Oral Presentation and Investigator / Key Opinion Leader Reception for Planned HDV Phase 3 D-LIVR Study at Global Hepatitis Summit 2018™
PALO ALTO, Calif., June 4, 2018 /PRNewswire/ -- Eiger BioPharmaceuticals, Inc. (EIGR), focused on the development and commercialization of targeted therapies for rare diseases, announced today ...
June 4, 2018
Athenex Names Christina Wang as Vice President of Clinical Operations and Corporate Development, Asia Pacific
BUFFALO, N.Y., June 04, 2018 (GLOBE NEWSWIRE) -- Athenex, Inc. (ATNX), a global biopharmaceutical company dedicated to the discovery, development and commercialization of novel therapies ...
June 1, 2018
BrainStorm to Host Call Following President Trump's Citing of Company's ALS Treatment During "Right-to-Try" Bill Signing
NEW YORK and PETACH TIKVAH, Israel, June 1, 2018 /PRNewswire/ -- BrainStorm Cell Therapeutics Inc. (BCLI), a leading developer of adult stem cell therapeutics for neurodegenerative diseases, ...
June 1, 2018
BioDelivery Sciences to Present at the William Blair 2018 Growth Stock Conference
RALEIGH, N.C., June 01, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc., (BDSI), a leading specialty pharmaceutical company in the field of pain management and ...
June 1, 2018
Kitov Announces Pricing of $8,150,000 Registered Direct Offering
TEL-AVIV, Israel, June 01, 2018 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (NASDAQ/TASE: KTOV), an innovative biopharmaceutical company, today announced that it has entered into definitive ...
June 1, 2018
Sensorion to Present at the 2018 BIO International Convention
MONTPELLIER, France, June 01, 2018 (GLOBE NEWSWIRE) -- Sensorion (FR0012596468 – ALSEN), a biotech company specializing in the treatment of inner ear diseases, will present ...
May 31, 2018
Kuros Biosciences to Propose Appointment of New Board Members at AGM
SCHLIEREN (ZURICH), Switzerland, May 31, 2018 (GLOBE NEWSWIRE) -- Kuros Biosciences (SIX:KURN) will propose the appointment of CEO Joost de Bruijn, as well as three ...
May 31, 2018
FDA Approves Kitov’s Consensi™ for Treatment of Osteoarthritis Pain and Hypertension
TEL AVIV, Israel, May 31, 2018 (GLOBE NEWSWIRE) -- Kitov Pharma Ltd. (NASDAQ: KTOV; TASE: KTOV), an innovative biopharmaceutical company, announced today that the U.S. ...
May 31, 2018
Molecular Templates to Present at the Jefferies Global Healthcare Conference
AUSTIN, Texas, May 31, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (MTEM) (“Molecular”), a clinical-stage oncology company focused on the discovery and development of the ...
May 31, 2018
TherapeuticsMD Announces Clinical Abstract at the 2018 ASCO Annual Meeting
BOCA RATON, Fla.--(BUSINESS WIRE)--TherapeuticsMD, Inc. (TXMD), an innovative women’s healthcare company, today announced the availability of clinical data from the REJOICE trial for IMVEXXY™ (estradiol ...
May 31, 2018
TRACON Pharmaceuticals to Present at the Jefferies 2018 Healthcare Conference
SAN DIEGO, May 31, 2018 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted ...
May 31, 2018
Reata Announces Orphan Drug Designation From the European Commission for Bardoxolone Methyl for the Treatment of Alport Syndrome
IRVING, Texas, May 31, 2018 (GLOBE NEWSWIRE) -- Reata Pharmaceuticals, Inc. (RETA), a clinical-stage biopharmaceutical company, today announced that the European Commission (EC) has granted ...
May 31, 2018
Inspire Medical Systems, Inc. to Present at the Goldman Sachs 39th Annual Global Healthcare Conference
MINNEAPOLIS, May 30, 2018 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative ...
May 31, 2018
AIT Therapeutics to Present at the Jefferies 2018 Global Healthcare Conference
NEW YORK, May 30, 2018 (GLOBE NEWSWIRE) -- AIT Therapeutics, Inc. (AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide ...
May 31, 2018
Zealand Pharma will attend the Jefferies Global Healthcare Conference on June 5-8, 2018 in New York
Copenhagen, May 31, 2018 - Mats Blom, Executive Vice President and Chief Financial Officer (CFO) of Zealand Pharma, will attend the Jefferies Global Healthcare Conference ...
May 31, 2018
Arcturus Announces Management Appointments; Company Founder Joseph E. Payne Reinstated as President and CEO
SAN DIEGO, May 31, 2018 (GLOBE NEWSWIRE) -- Arcturus Therapeutics Ltd. (ARCT), a leading RNA medicines company, today announced that Dr. Peter Farrell has been named ...
May 31, 2018
miRagen Therapeutics to Present at Jefferies 2018 Global Healthcare Conference on Thursday, June 7th
BOULDER, Colo., May 31, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, ...
May 31, 2018
APTOSE Enters into US$20 Million Common Share Purchase Agreement with Aspire Capital Fund, LLC
SAN DIEGO and TORONTO, May 31, 2018 (GLOBE NEWSWIRE) -- Aptose Biosciences Inc. (“Aptose” or the “Company”) (APTO) (APS.TO), a clinical-stage company developing highly differentiated therapeutics ...
May 31, 2018
Mustang Bio to Present at June Investor Conferences
NEW YORK, May 31, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (MBIO), a Fortress Biotech (FBIO) Company focused on the development of novel immunotherapies ...
Page 36 of 117